Lodin Klara, Da Silva Cristina Oliveira, Wang Gottlieb Anne, Bulatovic Ivana, Rück Andreas, George Isaac, Cohen David J, Braunschweig Frieder, Svenarud Peter, Eriksson Maria J, Haugaa Kristina H, Dalén Magnus, Shahim Bahira
Division of Cardiology, Department of Medicine, Karolinska Institutet, Solna S1:02, Stockholm 171 76, Sweden.
Division of Cardiothoracic Surgery, New York Presbyterian Hospital, College of Physicians and Surgeons of Columbia University, New York, NY, USA.
Eur Heart J. 2025 Jul 21;46(28):2795-2805. doi: 10.1093/eurheartj/ehaf195.
Mitral valve prolapse (MVP) is associated with progressive mitral regurgitation (MR) requiring surgical correction. A subset of patients with MVP experience ventricular arrhythmias (VA), and mitral annular disjunction (MAD) has been reported as a risk factor. This study aimed to assess the long-term risk of VA in patients with MAD and MVP undergoing mitral valve surgery for MR.
Patients with MVP with moderate or severe degenerative MR undergoing mitral valve surgery (repair or replacement) in 2010-22 at Karolinska University Hospital were included. Mitral annular disjunction length, referring to true MAD, was measured at end systole on pre- and post-operative transthoracic echocardiography. The primary outcome consisted of VA including hospitalizations, outpatient visits or ablation for confirmed sustained or non-sustained ventricular tachycardia, or high burden of premature ventricular complexes and assessed from medical records.
Of 599 patients undergoing mitral valve surgery, 96 (16%) had pre-operative MAD. The median MAD length was 8.0 [inter-quartile range (IQR) 5.0-10.0] mm. Compared with patients without MAD, patients with MAD were younger (55 ± 15 vs 63 ± 11 years), were more often women (31% vs 17%), and had more Barlow's disease (70% vs 27%). Mitral annular disjunction was surgically corrected in all patients. During a median follow-up time of 5.4 (IQR 2.8-7.5) years, patients with pre-operative MAD had a higher risk of VA (hazard ratio adjusted for age and sex 3.33, 95% confidence interval 1.37-8.08) regardless of repair/replacement (Pinteraction = .18).
Mitral annular disjunction in patients with MVP and MR was associated with a three-fold increased long-term risk of VA post-mitral valve surgery, despite anatomical correction of MAD.
二尖瓣脱垂(MVP)与需要手术矫正的进行性二尖瓣反流(MR)相关。一部分MVP患者会经历室性心律失常(VA),二尖瓣环分离(MAD)被报道为一个风险因素。本研究旨在评估因MR接受二尖瓣手术的MAD和MVP患者发生VA的长期风险。
纳入2010年至2022年在卡罗林斯卡大学医院因中度或重度退行性MR接受二尖瓣手术(修复或置换)的MVP患者。二尖瓣环分离长度,指真正的MAD,在术前和术后经胸超声心动图的收缩末期测量。主要结局包括VA,包括因确诊的持续性或非持续性室性心动过速住院、门诊就诊或消融,或室性早搏负担过重,并从病历中评估。
在599例接受二尖瓣手术的患者中,96例(16%)术前存在MAD。MAD长度中位数为8.0[四分位间距(IQR)5.0 - 10.0]mm。与无MAD的患者相比,有MAD的患者更年轻(55±15岁 vs 63±11岁),女性更常见(31% vs 17%),且更多患有巴洛病(70% vs 27%)。所有患者的二尖瓣环分离均通过手术矫正。在中位随访时间5.4(IQR 2.8 - 7.5)年期间,术前有MAD的患者发生VA的风险更高(年龄和性别校正后的风险比为3.33,95%置信区间1.37 - 8.08),无论修复/置换情况如何(P交互作用 = 0.18)。
MVP和MR患者的二尖瓣环分离与二尖瓣手术后发生VA的长期风险增加三倍相关,尽管MAD已进行解剖矫正。